Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source
Clinical Characterization of Enzyme and Transporter Precipitants to Evaluate Drug-Drug Interactions for Orforglipron, a Small Molecule Glucagon-Like Peptide-1 Receptor Agonist. [PDF]
Morse BL +7 more
europepmc +1 more source
Etoposide dosing challenges in a testicular cancer patient with hepatic impairment and drug-drug interactions-a case report. [PDF]
Op 't Hoog CJP +5 more
europepmc +1 more source
Predicting drug-drug interactions between ayahuasca alkaloids and SSRIs using physiologically based pharmacokinetic modeling. [PDF]
Ribeiro GSG +13 more
europepmc +1 more source
Comprehensive pharmacovigilance assessment of pairwise drug-drug interactions and acute pancreatitis in the FDA adverse event reporting system: focus on incretin-based drugs. [PDF]
Kazume I +4 more
europepmc +1 more source
Potential drug-drug interactions in hospitalized patients with acute coronary syndrome at a tertiary care hospital in upper Egypt. [PDF]
Ghabesha AA +3 more
europepmc +1 more source
Related searches:
Aptamer–Protein Interactions: From Regulation to Biomolecular Detection
Chemical Reviews, 2023Jie Tan, Quan Yuan, Weihong Tan
exaly
Probing and Manipulating Noncovalent Interactions in Functional Polymeric Systems
Chemical Reviews, 2022Hongbo Zeng, Hao Zhang, Jingsi Chen
exaly

